logo

For the Inventor, By the Inventor

Raleigh, NC, United States of America

Sprout Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 15

% Expired Patents = 33.3


Trademarks = 2

Forward Citations = 48

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Angelo Ceci (6 out of 24 patents)

silverMedal Kenneth Robert Evans (6 out of 8 patents)

bronzeMedal Franco Borsini (6 out of 8 patents)

4.  Marcus Schindler (5 out of 15 patents)

5.  Vladimir Hanes (1 out of 3 patents)

6.  Anna Elisabeth Verbeek (1 out of 2 patents)

7.  Ramiro Castro (1 out of 2 patents)

8.  Ralf Lotz (1 out of 16 patents)

9.  Jaroslaw Mazurek (1 out of 2 patents)

10.  Mihaela Pop (1 out of 4 patents)

11.  Astrid Volz (1 out of 1 patent)

12.  Fabio Paleari (1 out of 11 patents)

13.  Enzo Cereda (24 patents)

14.  Giovanni Battista Schiavi (8 patents)

15.  Alessandro Brambilla (2 patents)


15 patents:

1. 11058683 - Treating sexual desire disorders with flibanserin (2021-07-13),
2. 10874668 - Use of Flibanserin in the treatment of obesity (2020-12-29),
3. 10675280 - Treating sexual desire disorders with flibanserin (2020-06-09),
4. 10596170 - Treatment of vasomotor symptoms (2020-03-24),
5. 10335407 - Use of flibanserin in the treatment of obesity (2019-07-02),
6. 10307420 - Treating sexual desire disorders with flibanserin (2019-06-04),
7. 9782403 - Treating sexual desire disorders with flibanserin (2017-10-10),
8. 9763936 - Flibanserin for the treatment of urinary incontinence and related diseases (2017-09-19),
9. 9730927 - Use of flibanserin in the treatment of obesity (2017-08-15),
10. 9546141 - Salts (2017-01-17),
11. 9468639 - Treating sexual desire disorders with flibanserin (2016-10-18),
12. 8785458 - Use of flibanserin in the treatment of obesity (2014-07-22),
13. 8722682 - Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity (2014-05-13),
14. 8227476 - Use of flibanserin in the treatment of obesity (2012-07-24),
15. 8227471 - Treating sexual desire disorders with flibanserin (2012-07-24),
Company Overview
Sprout Pharmaceuticals, Inc. is a biopharmaceutical company based in Raleigh, North Carolina, specializing in the development of innovative treatments for women's health issues. The organization focuses on addressing unmet medical needs, particularly in the realm of female sexual health. Through rigorous research and development, Sprout aims to enhance the quality of life for women by providing effective therapeutic options that empower them to take control of their health and well-being.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

15 Patents

#55 in Raleigh, NC

#466 in North Carolina

#21,085 in US

#39,991 in the World

Raleigh, NC (US)
Raleigh, NC, United States of America

Sprout Pharmaceuticals, Inc.

Forward Citations = 48

12 inventors:

goldMedal Angelo Ceci (6 out of 24 patents)

silverMedal Kenneth Robert Evans (6 out of 8 patents)

bronzeMedal Franco Borsini (6 out of 8 patents)

4.  Marcus Schindler (5 out of 15 patents)

5.  Vladimir Hanes (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sprout Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/sprout-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…